EPCAM and neoplasm: Subsequently, colony formation and tumor sphere assays revealed significant decreases in CFUs for CD24, CD133, EpCAM, and E-cadherin shRNA knockdown clones compared to sheGFP controls (P < 0.05, Fig. 5c, and d).